Among the 11 hematological and biochemical biomarkers found to be associated with the risk of invasive breast cancer, some were inflammatory markers, such as white blood cell count, neutrophil count, and CRP, while others were endogenous hormones, such as SHBG, IGF-1, and testosterone. Here, CRP is linked to invasive breast carcinoma.